A national survey of endomyocardial biopsy procedures was conducted in Japan. Questionnaires were mailed to 852 institutions and statistical analysis of the 213 completed questionnaires (25.0% of the total) was performed. Cardiac biopsies were being performed at 134 of these institutions (62.9%), representing a 5.5-fold increase over 1980. A total of 19,964 cardiac biopsies have been performed in Japan. Specimens were obtained from the right ventricle at 113 institutions, and from the left ventricle at 76 centers. The Konno-Sakakibara bioptome was used at 32 institutions, whereas the long sheath method was used at 98 institutions. Sixty of the institutions (44.8%) had encountered ventricular wall perforation. The perforation rate of the two ventricles combined was 0.7% (147 of 19,964 cases), with a mortality rate of 0.05% (10 of 19,964 cases). Endomyocardial biopsy has become widespread in Japan, and its safety was ascertained by this national survey. (Jpn Circ J 1998; 62: 909 -912) 
catheter-type endomyocardial biopsy method was first developed in 1962 by Konno and Sakakibara. 1 This approach is indispensable for the diagnosis of myocarditis and heart transplant rejection, 2, 3 and has been applied for detection of virus genome from biopsy samples, 4 not to mention genetic analyses and so on. But it is still viewed by some as being dangerous with restricted application. Thus, in order to clarify the complications with the use of this method and ensure greater safety, along with its widespread application, its present status needed to be made clear. In a 1980 survey, Sekiguchi et al described the risks and complications of this method. 5 However, one should consider that the use of cardiac catheterization is now widespread due to improvements in equipment, and its indications have been expanded. Therefore, we conducted a national survey on the use of endomyocardial biopsy in Japan.
Methods

Questionnaires
In 1992, we sent a detailed questionnaire to 852 institutions (circulation training institutions and circulation training-related institutions designated by the Japan Circulation Society), and 213 responses (25.0% of the total) were analyzed statistically.
Statistical Analysis
Mortality rates in patients with left or right ventricular 
Results
Current Status of Endomyocardial Biopsy
Responses were obtained from 213 institutions: 58 university hospitals and 155 general hospitals. Of the 213 institutions that completed the questionnaire, 134 (62.9%) performed endomyocardial biopsy, and the remaining 79 (37.1%) gave the following reasons for not using this method: 58 institutions stated that it was technically impossible, 25 reported that it was too dangerous, 10 described it as meaningless and 7 reported that there were no patients with indications for this procedure. Some 134 institutions were performing cardiac biopsies; 49 out of 58 (84.5%) university hospitals, and 85 out of 155 (54.8%) general hospitals. Fig 1 illustrates Methods of accessing the heart with bioptome were via the femoral artery/vein at the majority of institutions, with the right heart biopsied at 108 institutions (101 via the femoral vein, 7 via the saphenous vein, 5 via the right internal jugular vein, 2 via the right subclavian vein, and 2 via the right brachiocubital vein), and the left heart biopsied at 74 institutions (via the femoral artery at all 74, and via the right brachial artery at 7 centers).
As regards the instruments used for endomyocardial biopsy, the long sheath method was used at the majority (98) of the institutions (Table 2 ), but in many cases the specific brand was not recorded. However, in most cases the tip of the sheath was either straight or bent at a 45°a ngle. Bioptomes manufactured by Cordis Co, (Miami, FL, USA) were the most frequently used (65 institutions), followed by those manufactured by Mansfield Co, (Watertown, MA, USA; 15 institutions). Bioptomes with small jaws were used at 59 institutions and those with large jaws were used at 11 centers. The Konno-Sakakibara bioptome was used at 32 institutions, with small or mediumsized jaws used in the majority. Biopsy site specimens were obtained from the right ventricle at 113 institutions (interventricular septum at 104, free wall at 26). Specimens were also obtained from the left ventricle at 76 institutions (posterolateral wall at 59, apex at 33), sometimes in addition to those obtained from the right ventricle. Specimens were obtained from the right atrium at 8 institutions (free wall at 7, interatrial septum at 1).
Regarding the number of specimens obtained per procedure, 1-6 specimens were obtained from the right ventricle (mean, 2.6), 1-8 from the left ventricle (mean, 2.8), and 1-4 from the right atrium (mean, 2.2).
Complications
Sixty institutions had encounterd ventricular perforation (44.8%), 59 had experienced arrhythmias (44.3%) and one reported valve perforation (0.7%).
The underlying disease of ventricular perforation was recorded in a total of 111 cases, dilated cardiomyopathy in 34 cases (30.1%), hypertrophic cardiomyopathy in 34 The diagnosis of perforation was most frequently confirmed by visualization of a pericardial effusion on echocardiography (56 cases). The finding of contrast medium leakage into the pericardial cavity on ventriculography (16 cases) and decreased movement of cardiac silhouette on fluoroscopy (14 cases) were also frequent indicators of perforation.
Regarding treatment of the perforation, 14 institutions used puncture and aspiration as the only methods of drainage and 37 institutions used continuous drainage. At 28 of these 37 institutions a surgical incision was made (left thoracotomy at 6, pericardiotomy from the epigastric region at 22), while in the remaining 9 institutions continuous drainage was performed using a puncture method. Direct suturing after thoracotomy was also performed at 25 institutions.
As regards the number of perforated cases and their outcome, right ventricle perforations occurred in a total of 115 patients, of whom 86 survived and 6 died (5.2%); the outcome was not recorded in the remaining 23. Left ventricle perforations occurred in a total of 31 patients, of whom 25 survived and 4 died (12.9%); the outcome was not recorded in the other 2. The mortality rate showed a higher tendency in cases with left ventricular perforation than with right ventricular perforation, but it was not statistically significant (p=0.22). The right atrium was perforated in only 1 case; the patient did not die of this complication.
The total perforation rate of the two ventricles combined was 0.7% (147 of 19,964 cases), with a mortality rate of 0.05% (10 of 19,964 cases).
In response to the final survey question, 'Do you add any refinements to enhance the safety of endomyocardial biopsy?', 11 institutions reported that they obtained specimens after confirming the biopsy site by right ventriculography, 7 institutions obtained specimens after confirming the location by fluoroscopy, 7 institutions obtained specimens by pressing down the myocardium after adequately opening the bioptome, 7 reported that they never use excessive force, 6 institutions restrict the number of physicians performing endomyocardial biopsy, 4 institutions always obtain specimens from the septum, 3 avoid collection of specimens from the same site, 3 institutions always obtain specimens using 2-dimensional echocardiographic guides, 3 institutions always perform echocardiography after endomyocardial biopsy, and 2 institutions obtain specimens while intracardiac electrocardiography is being performed.
Discussion
Endomyocardial biopsy has become widely used in Japan in the 36 years since its development, because of the wealth of information that is provided by a few milligrams of biopsied tissue. Its use has expanded beyond morphological research to include the biochemical, immunological 6, 7 and genetic engineering fields. Indications for the procedure are not limited to patients with cardiomyopathy and specific heart muscle disease. Patients receiving heart transplants can also benefit from the procedure, which serves to determine the presence/absence of rejection 2, 3 and to evaluate the therapeutic effect of immunosuppressant agents.
The present study was designed to assess the use of endomyocardial biopsy in Japan. Questionnaires were mailed to all 852 institutions, while only 213 (25.0%) of these responded. Because the circulation training-related institutions are certified on the basis of one board certified member of the Japanese Circlation Society and 15 hospital beds, we assumed that many of the hospitals targeted by the present study were too small to be equipped with cineangiographic devices. We thought this was one of the reasons for the low response rate. Among the 58 university hospitals responding there were 49 (84.5%) that performed cardiac biopsies, and they more or less typify present conditions in Japan. However, general hospitals used this method at a high rate (85 of 155 institutions, or 54.8%). This would appear to indicate a low response rate from institutions where the procedure was not in place. The size of these general hospitals, their use/non-use of cineangiographic systems, etc could not be determined just by the questionnaire results. The number of institutions that performed endomyocardial biopsy has increased more than 5-fold since 1980, when Sekiguchi et al 5 conducted their survey, with the number of cases reaching 2,500 per year in 1991. Use of the Konno-Sakakibara bioptome, 1 the most common method at the time of the previous survey, has largely been replaced by the long sheath method. Endomyocardial biopsy alone was performed in rather few cases, usually being performed in conjunction with cardiac catheterization. Therefore, in the majority of cases, specimens were collected from the right ventricle via the inguinal approach. The mean number of specimens obtained per procedure was 2.6 from the right ventricle and 2.8 from the left ventricle, which is rather low, considering the possibility of sampling error. 8 The most troublesome complication was perforation, which was encountered in a relatively high percentage of the institutions (60 of 134, 45%). Symptoms and signs at the time of perforation, in addition to those of cardiac tamponade, were frequently those induced by the vasovagal reflex. Few cases progressed quickly to death after the perforation, especially in cases of right ventricle perforation, suggesting that such cases could be rescued if appropriate treatment was administered. The following measures are recommended when perforation does occur. When bradycardia develops, atropine sulfate should be administered intravenously to counteract the vasovagal reflex. 9 Intravenous fluids replacement should be administered as soon as possible to prevent dehydration, because endomyocardial biopsy is usually performed with the patient in a fasting or near-fasting state. 10 In previous studies, complications such as coronary artery fistula 11, 12 and ruptured chordae tendineae of the tricuspid valve 13 were reported. The mortality rate due to perforation in our survey was 0.05% (10 of 19,964 cases), which was similar to the rate of 0.08% (3 of 3,931 cases) noted in the survey of Sekiguchi et al, 5 and confirmed the safety of this procedure. The fact that the mortality rate had not risen, despite the significant increase in the number of institutions performing endomyocardial biopsy, suggests that this examination can be performed safely even by less experienced physicians. Mortality rates were somewhat higher among Japanese Circulation Journal Vol.62, December 1998 patients with left ventricular perforation (12.9%, 4/31 cases) than in those with right ventricular perforation (5.2%, 6/115 cases). Additional investigation of mortality rates is needed to devise more definitive safety measures, as the outcome after perforation was unclear in some cases, and details were not available for some of the fatalities.
In a survey of patients undergoing coronary arteriography from 1984 to 1987 recorded by the US Society for Cardiac Angiography and Interventions (SCAI), 14 a mortality rate of 0.1% (218 of 222,553 cases) was reported, which exceeds the rate in the present survey. These figures do not point to endomyocardial biopsy as a particularly high-risk heart catheterization procedure. When heart transplantation becomes accepted in Japan, the number of cases undergoing endomyocardial biopsy will increase further. BaraldiJunkins et al studied a series of 2,454 cases undergoing right ventricle endomyocardial biopsy after heart transplantation and reported an incidence of right ventricle perforation of only 0.08% (2 cases) and no deaths. 15 This incidence was lower than that reported by Deckers et al 16 in a series of 546 patients with cardiomyopathy (perforation rate: 1.3%, mortality rate: 0.3%), which illustrates the safety and usefulness of endomyocardial biopsy in post-transplant patients. Baraldi-Junkins et al also noted that because there is no pericardium in heart transplant patients, cardiac tamponade does not develop even if perforation occurs, thus explaining the high survival rate in their series. 15 Recently, in addition to histopathological examinations of biopsied myocardium, research involving virological, immunohistochemical, cytochemical and biochemical techniques has expanded. Study methods using micromaterials have been refined and can be applied to myocardial biopsy as well. In the future, we will focus on the instruments and methods used for this procedure and discuss improvements that can further enhance its safety and availability.
